Results 211 to 220 of about 46,425 (297)

Mitochondria Are Direct Targets of the Lipoxygenase Inhibitor MK886 [PDF]

, 2002
Arianna Gugliucci, Laura Ranzato, Luca Scorrano, Raffaele Colonna, Valeria Petronilli, Claudia Cusan, Maurizio Prato, Mariangela Mancini, Francesco Pagano, Paolo Bernardi   +9 more
openalex   +1 more source

Epigenome Modifying Tools In Asthma [PDF]

, 2015
Adcock,, Brook, PO, Durham, AL, Perry, M
core   +1 more source

Hybrid pharmacophore-based design of novel 5-lipoxygenase inhibitors: Molecular docking and dynamics simulation studies

Jiangmiao Pang, Kit‐Kay Mak, Mallikarjuna Rao Pichika, Vasudeva Rao Avupati   +3 more
openalex   +1 more source

Flavocoxid, a dual inhibitor of cyclooxygenase and 5‐lipoxygenase, blunts pro‐inflammatory phenotype activation in endotoxin‐stimulated macrophages [PDF]

, 2009
Domenica Altavilla, Francesco Squadrito, Alessandra Bitto, Francesca Polito, B.P. Burnett, Vincenzo Di Stefano, Letteria Minutoli   +6 more
openalex   +1 more source

Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor [PDF]

, 2012
Gretchen Bain, Christopher D. King, Kevin Schaab, Melissa Rewolinski, Virginia Norris, Claire Ambery, J. Bentley, M. Yamada, Angelina M. Santini, Jeroen van de Wetering de Rooij, Nicholas Stock, Jasmine Zunic, John H. Hutchinson, Jilly F. Evans   +13 more
openalex   +1 more source

Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation". [PDF]

Life (Basel)
Chatzipieris FP, Petsas E, Lambrinidis G, Vassiliou S, Chasapis CT.   +4 more
europepmc   +1 more source

2D-QSAR Study of Thiazole derivatives as 5-Lipoxygenase inhibitors [PDF]

Danilo Lusbin Ariza Rúa, Julio Hurtado Márquez, Humberto Marbello-Peña, Edisson Chavarro‐Mesa, Liliana Carranza-López   +4 more
openalex   +1 more source

Development of novel salicylic acid derivatives with dual anti-inflammatory and anti-arthritic potentials: synthesis, <i>in vitro</i> bio-evaluation, and <i>in silico</i> toxicity prediction with molecular modeling simulations. [PDF]

RSC Adv
Hesham K, Aboulthana WM, Ragab A.
europepmc   +1 more source

Developing the risk prediction model (ProlncSig) from lipoxygenase pathway-related lncRNAs for prognosis prediction in breast cancer. [PDF]

RNA Biol
Fu X, Wang W, Downs BM, Li J.
europepmc   +1 more source

Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors. [PDF]

Int J Med Chem, 2014
Doiron JA, Métayer B, Richard RR, Desjardins D, Boudreau LH, Levesque NA, Jean-François J, Poirier SJ, Surette ME, Touaibia M.   +9 more
europepmc   +1 more source